{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:27:33Z","timestamp":1769574453511,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00405-021-07234-1","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:04:06Z","timestamp":1643587446000},"page":"2197-2201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study"],"prefix":"10.1007","volume":"279","author":[{"given":"Fabrice","family":"Giraudet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Selvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Kerckhove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fantine","family":"Barreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Busserolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Cabrespine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Chaleteix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lemal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-6588","authenticated-orcid":false,"given":"David","family":"Balayssac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"7234_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0039-1684039","volume":"40","author":"RM DiSogra","year":"2019","unstructured":"DiSogra RM (2019) The impact of pharmaceutical side effects on audiological and vestibular measurements. Semin Hear 40:97\u2013103. https:\/\/doi.org\/10.1055\/s-0039-1684039","journal-title":"Semin Hear"},{"key":"7234_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D (2016) Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol 43:676\u2013681. https:\/\/doi.org\/10.1053\/j.seminoncol.2016.11.004","journal-title":"Semin Oncol"},{"key":"7234_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fphar.2017.00086","volume":"8","author":"N Kerckhove","year":"2017","unstructured":"Kerckhove N, Collin A, Cond\u00e9 S et al (2017) Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol 8:86. https:\/\/doi.org\/10.3389\/fphar.2017.00086","journal-title":"Front Pharmacol"},{"key":"7234_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2706","author":"T Li","year":"2019","unstructured":"Li T, Timmins HC, King T et al (2019) Characteristics and risk factors of bortezomib induced peripheral neuropathy: a systematic review of phase III trials. Hematol Oncol. https:\/\/doi.org\/10.1002\/hon.2706","journal-title":"Hematol Oncol"},{"key":"7234_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.637593","volume":"12","author":"M Selvy","year":"2021","unstructured":"Selvy M, Kerckhove N, Pereira B et al (2021) Prevalence of Chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study. Front Pharmacol 12:637593. https:\/\/doi.org\/10.3389\/fphar.2021.637593","journal-title":"Front Pharmacol"},{"key":"7234_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4103\/0019-509X.200675","volume":"53","author":"P Anoop","year":"2016","unstructured":"Anoop P, Patil CN, Joshi VS et al (2016) Sensorineural deafness: An uncommon irreversible adverse effect of bortezomib. Indian J Cancer 53:459. https:\/\/doi.org\/10.4103\/0019-509X.200675","journal-title":"Indian J Cancer"},{"key":"7234_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2403723","volume":"19","author":"M Engelhardt","year":"2005","unstructured":"Engelhardt M, M\u00fcller AMS, Maier W, W\u00e4sch R (2005) Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patient. Leukemia 19:869\u2013870. https:\/\/doi.org\/10.1038\/sj.leu.2403723","journal-title":"Leukemia"},{"key":"7234_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"1990","unstructured":"Postma TJ, Aaronson NK, Heimans JJ et al (1990) (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer Oxf Engl 41:1135\u20131139. https:\/\/doi.org\/10.1016\/j.ejca.2005.02.012","journal-title":"Eur J Cancer Oxf Engl"},{"key":"7234_CR9","unstructured":"American speech-language-hearing association (ASHA) self-test for hearing loss. https:\/\/www.asha.org\/public\/hearing\/self-test-for-hearing-loss\/. Accessed 21 Oct 2021"},{"key":"7234_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14992020400050014","volume":"43","author":"S Gatehouse","year":"2004","unstructured":"Gatehouse S, Noble W (2004) The speech, spatial and qualities of hearing scale (SSQ). Int J Audiol 43:85\u201399. https:\/\/doi.org\/10.1080\/14992020400050014","journal-title":"Int J Audiol"},{"key":"7234_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdt409","volume":"25","author":"P Alberti","year":"2014","unstructured":"Alberti P, Rossi E, Cornblath DR et al (2014) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol Off ESMO 25:257\u2013264. https:\/\/doi.org\/10.1093\/annonc\/mdt409","journal-title":"Ann Oncol Off ESMO"},{"key":"7234_CR12","volume-title":"Avis d\u2019experts relatif \u00e0 l\u2019\u00e9volution du discours public en mati\u00e8re de consommation d\u2019alcool en France","author":"Sant\u00e9 Publique France","year":"2017","unstructured":"Sant\u00e9 Publique France (2017) Avis d\u2019experts relatif \u00e0 l\u2019\u00e9volution du discours public en mati\u00e8re de consommation d\u2019alcool en France. Sant\u00e9 Publique France, Paris"},{"key":"7234_CR13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers ASCO guidline update. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.20.01399","journal-title":"J Clin Oncol"},{"key":"7234_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/02841860701558823","volume":"47","author":"CS Chim","year":"2008","unstructured":"Chim CS, Wong LG (2008) Deafness associated with the use of bortezomib in multiple myeloma. Acta Oncol Stockh Swed 47:323\u2013324. https:\/\/doi.org\/10.1080\/02841860701558823","journal-title":"Acta Oncol Stockh Swed"},{"key":"7234_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/1534735418788667","volume":"17","author":"WI Zhi","year":"2018","unstructured":"Zhi WI, Ingram E, Li SQ et al (2018) Acupuncture for bortezomib-induced peripheral neuropathy: not just for pain. Integr Cancer Ther 17:1079\u20131086. https:\/\/doi.org\/10.1177\/1534735418788667","journal-title":"Integr Cancer Ther"},{"key":"7234_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbrc.2014.11.070","volume":"456","author":"JN Lee","year":"2015","unstructured":"Lee JN, Kim S-G, Lim J-Y et al (2015) Proteasome inhibitors induce auditory hair cell death through peroxisome dysfunction. Biochem Biophys Res Commun 456:269\u2013274. https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.070","journal-title":"Biochem Biophys Res Commun"},{"key":"7234_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2015.10.023","volume":"163","author":"S Delmaghani","year":"2015","unstructured":"Delmaghani S, Defourny J, Aghaie A et al (2015) Hypervulnerability to sound exposure through impaired adaptive proliferation of peroxisomes. Cell 163:894\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2015.10.023","journal-title":"Cell"},{"key":"7234_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cell.2015.10.060","volume":"163","author":"P Mardones","year":"2015","unstructured":"Mardones P, Hetz C (2015) Peroxisomes get loud: a redox antidote to hearing loss. Cell 163:790\u2013791. https:\/\/doi.org\/10.1016\/j.cell.2015.10.060","journal-title":"Cell"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-07234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-021-07234-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-07234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:44:25Z","timestamp":1647542665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-021-07234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["7234"],"URL":"https:\/\/doi.org\/10.1007\/s00405-021-07234-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}